Australia's largest stock trading and investment forum Australia's #1 stock forum

MSB

Click for more information

1.90%

$1.03 mesoblast limited

Ann: MSB Files GvHD Clinical Efficacy and Safety Data with US FDA, page-74

First 74 Last

Share
Profile

Follow
Barman76

3,996 Posts.

314

04/01/20

01:37

Post #: 42220643
Share

Originally posted by markhughes: ↑

So I think something that was not discussed locally but noted on the Cantor note (thanks @Anjo-Roch) was that MSB provided the FDA with additional data from Mt Sinai which was using current standard of care, and in a sort of retrospective analysis reiterated that remestemscel was effective. Perhaps someone with more technical knowledge can comment on that? But maybe that's what the US took out of it and hence the rise as it further increases probability of success. Us Aussie schmucks just saw a delay as the takeaway.

Expand

I suspect the additional information may have been needed to satisfy the FDA

MSB Price at posting: $2.10 Sentiment: Buy Disclosure: Held
3 Upvote

1 Great analysis

Reply

First 74 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.03		Change -0.020(1.90%)		Mkt cap ! $1.164B

Open	High	Low	Value	Volume
$1.06	$1.06	$1.02	$3.873M	3.757M

Buyers (Bids)

No.	Vol.	Price($)
17	111884	$1.03

Sellers (Offers)

Price($)	Vol.	No.
$1.04	232641	32

View Market Depth

No.	Vol.	Price($)
15	84052	1.030
22	207349	1.025
20	215588	1.020
21	346662	1.015
18	677734	1.010

Price($)	Vol.	No.
1.035	208752	30
1.040	410083	18
1.045	122794	16
1.050	114163	9
1.055	47902	7

Last trade - 13.15pm 16/05/2024 (20 minute delay)


Last $1.03			Change -0.020 ( 2.47 %)
Open	High		Low	Volume
$1.06	$1.06		$1.02	487529
Last updated 13.33pm 16/05/2024 ?

MSB (ASX) Chart